×
| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 24 Oct 2024 | Sharekhan | Buy | ₹1,534.65 | ₹1,874 | 19.9% | moneycontrol | View |
| 30 Jan 2024 | Sharekhan | — | ₹700.1 | ₹800 | -49.8% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| Strides Pharma Science Limited | 6568.75 | 1218.95 | 5536.32 | 13.22 | 7,517 | 20.1 |
| Aarti Pharmalabs Limited | 4319.02 | 479.56 | 4322.73 | 5.29 | 7469 | 28.0 |
| Marksans Pharma Limited | 7745.71 | 1136.9 | 7544.27 | 2.5 | 7449 | 21.3 |
STRIDES PHARMA SCIENCE LIMITED, with Security Code 532531, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 554.8 | 554.8 | 610.0 | 550.9 | 556.0 | 498.6 | 522.2 | 553.6 |
| Expenses | 493.7 | 493.7 | 546.9 | 476.8 | 488.0 | 431.4 | 459.9 | 472.4 |
| Operating Profit | 61.0 | 61.0 | 63.0 | 74.1 | 68.0 | 67.2 | 62.2 | 81.2 |
| OPM % | 11% | 11% | 10.33% | 13.45% | 12.23% | 13.48% | 11.92% | 14.67% |
| Other Income | 11.8 | 11.8 | 23.5 | 2.4 | 12.1 | 1.8 | 14.1 | 103.2 |
| Interest | 46.9 | 46.9 | 50.2 | 34.2 | 29.4 | 30.4 | 29.4 | 27.2 |
| Depreciation | 20.3 | 20.3 | 22.0 | 20.9 | 22.4 | 22.1 | 21.5 | 22.4 |
| Profit before tax | 5.7 | 5.7 | 14.4 | 21.4 | 28.4 | 16.4 | 25.4 | 134.8 |
| Tax % | -30.8% | 30.8% | 6.1% | 30.1% | -42.7% | 18.6% | -26.2% | 9.6% |
| Net Profit | 3.9 | 3.9 | 15.3 | 14.9 | 16.1 | 13.3 | 32.0 | 121.9 |
| EPS in Rs | 0.43 | 0.43 | 1.66 | 1.62 | 0 | 1.45 | 3.48 | 13.22 |
| Metrics | Mar 2024 | Jun 2024 | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,084.0 | 19.3 | 1,087.5 | 19.3 | 1,201.1 | 1,153.7 | 1,190.4 | 1,220.8 |
| Expenses | 902.9 | 20.6 | 882.3 | 20.6 | 978.1 | 943.4 | 972.5 | 990.3 |
| Operating Profit | 181.2 | -1.2 | 205.2 | -1.2 | 223.0 | 210.3 | 217.9 | 230.5 |
| OPM % | 16.71% | -6.43% | 18.87% | -6.43% | 18.57% | 18.23% | 18.3% | 18.88% |
| Other Income | -21.6 | 1.0 | 9.0 | 1.0 | 24.5 | 3.2 | -15.4 | 18.4 |
| Interest | 80.2 | 1.5 | 80.4 | 1.5 | 82.1 | 52.2 | 50.3 | 46.1 |
| Depreciation | 49.8 | 0.3 | 48.6 | 0.3 | 50.5 | 48.4 | 48.9 | 49.6 |
| Profit before tax | 37.7 | -2.0 | 88.9 | -2.0 | 118.7 | 115.3 | 130.7 | 161.9 |
| Tax % | -24.6% | 0% | -17.4% | 0% | -16.6% | -21.1% | -20% | -14% |
| Net Profit | 10.4 | -2.0 | 68.3 | -2.0 | 93.7 | 90.0 | 85.6 | 131.5 |
| EPS in Rs | 1.98 | -1.14 | 7.62 | -1.14 | 10.12 | 9.55 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 5% |
| 3 Years: | 3% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -13% |
| 3 Years: | -30% |
| TTM: | -16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 30% |
| 3 Years: | 73% |
| 1 Year: | 79% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 11% |
| 3 Years: | 14% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 34% |
| 3 Years: | 52% |
| TTM: | 265% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 30% |
| 3 Years: | 73% |
| 1 Year: | 79% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|